GA
Genmab AS
🇬🇧XLON.0MGBUnited KingdomHealthcare
DKKÂ 2,207.00DKKup +70.00 (+3.28%)ClosedEnd of day8:58 PM
PriceDKKÂ 2,207.00+70.00 (+3.28%)
Profile
- Healthcare
- Biotechnology
- United Kingdom
Identity
- Exchange
- London Stock Exchange . XLON
- Type
- Stock
- ISIN
- DK0010272202
- CUSIP
- Not reported
Company
- Employees
- 3,119
- Headquarters
- Copenhagen, United States
- Website
- https://www.genmab.com
- CEO
- Dr. Jan G.J. van de Winkel Ph.D.
Market
- Shares outstanding
- 65.3M
- Market cap
- DKKÂ 144.15B
Highlights
- Market cap
- DKKÂ 139.57B
- EPS LTM
- $1.28
- P/E LTM
- 21.52
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $4.13B-68.25%down year on year
- Net income
- $788.1M-85.61%down year on year
- Gross margin
- 93.03%-1.9%down year on year
- Free cash flow
- $867.34M-66.56%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.